US Patent 10828313 Synthetic composition for treating metabolic disorders
Patent 10828313 was granted and assigned to Glycom A/S on November, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10828313 Synthetic composition for treating metabolic disorders
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.